Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

Clinical trial NCT07223593 · RECRUITING

Trial details

NCT number: NCT07223593
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Arterial Disease

Start date: 2025-10-31
Primary completion: 2028-06-01
Enrollment: 1205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.